| Name | Title | Contact Details |
|---|
TVG-Medulla, LLC (Medulla) is a wellness-focused healthcare management organization providing incomparable support and services to more than 40 Chiro One Wellness Center locations. In addition to our full-scale management departments and a wide-range of Medulla career opportunities, Medulla also offers engaging wellness programs and education services to communities, employers and organizations across Chicagoland.
Altruista Health provides a suite of technology solutions that support collaborative, data-driven and person-centered approaches to population health management. Founded in 2007, Altruista Health has been recognized by Gartner as one of the fastest-growing care management technology companies serving complex care populations. Today, our solutions remove barriers to care, reduce avoidable healthcare expenses and improve health outcomes for more than 38 million people. Our GuidingCare™ platform is a web-based population health management system that enables health plans to maximize the value of their data and improve the quality of care for high-risk members. GuidingCare integrates data from a variety of systems, including medical and pharmacy claims, EMR/EHR, eligibility, HIEs and others, to power role-optimized workflow management tools for care coordination, quality improvement, care transitions management, utilization management, LTC/long term support services and more.
Universal Endoscopic Svc Inc is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Arkansas-based Beverly (NYSE: BEV) operates 351 nursing homes, 18 assisted living centers and 52 hospice and home health centers.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.